Tempur Sealy announced today the debut of Cocoon™ by Sealy, the company’s new offering in the below-$1,000 e-commerce space. Made with the high-quality materials that consumers expect from Sealy, Cocoon by Sealy is sold exclusively online at CocoonBySealy.com and delivered in a box directly to consumers’ doorsteps. A queen Cocoon by Sealy mattress sells for $849, including free shipping.
“Tempur Sealy is committed to having high-quality products available wherever and however consumers want to shop,” said Scott Thompson, Chairman, President and Chief Executive Officer of Tempur Sealy.
“Cocoon by Sealy is a logical extension of our family of products. We have products that serve just about every consumer need and at just about every price point,” Thompson added. “We entered this specialized distribution channel because we knew we could provide a product that meets the needs of this target consumer, is superior to the competition and consistent with our Sealy brand promise of quality and value.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7778651-cocoon-by-sealy-launch/
Stearns & Foster and Jonathan Scott, one of television’s most recognized home design experts, are teaming up again to bring inspired bedroom designs to consumers who have an eye for luxurious and trend-forward designs.
The collaboration features the Stearns & Foster Estate and Reserve Collections, both of which bring a premium look and feel to the master bedroom suite. Throughout the year, Scott will debut fresh new looks, seasonal tips and updates that can be completed on any budget, always keeping the Stearns & Foster bed at the center of any beautifully designed room.
To view the multimedia release go to:
https://www.multivu.com/players/English/7971453-stearns-foster-jonathan-scott-inspired-design/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
